Skip to main content

Connaughton Bernadette

In the past year, 8 open-market sale filings worth $989.9K and no purchases.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
$989.9K
8 filings
Net
−$989.9K
Bought minus sold
Companies
1
With open-market trades

Trades

Every Form 4 that lists Connaughton Bernadette as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

HALO Halozyme Therapeutics, Inc.

Director9 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 11, 2026 (view filing)5:43 PM ETAug 101 dayConnaughton BernadetteDirectorSSale−1.63K$102.80−$167.2K−3.9%40.4K after10b5-1
Jul 2, 2026 (view filing)4:42 PM ETJul 11 dayConnaughton BernadetteDirectorSSale−1.63K$76.71−$124.7K−3.7%42.0K after2 lots10b5-1
Jun 2, 2026 (view filing)Jun 11 dayConnaughton BernadetteDirectorSSale−1.63K$66.21−$107.6K−3.6%43.7K after10b5-1
May 5, 2026 (view filing)May 14 daysConnaughton BernadetteDirectorSSale−1.63K$63.48−$103.2K−4.1%38.5K after10b5-1
Jan 6, 2026 (view filing)Jan 51 dayConnaughton BernadetteDirectorSSale−2.00K$70.25−$140.5K−4.7%40.1K after10b5-1
Dec 1, 2025 (view filing)Dec 1Same dayConnaughton BernadetteDirectorSSale−829$71.60−$59.4K−1.9%42.1K after10b5-1
Nov 12, 2025 (view filing)Nov 102 daysConnaughton BernadetteDirectorSSale−2.00K$68.48−$137.0K−4.4%43.0K after10b5-1
Oct 1, 2025 (view filing)Oct 1Same dayConnaughton BernadetteDirectorSSale−2.00K$75.24−$150.5K−4.3%45.0K after2 lots10b5-1
Sep 2, 2025 (view filing)Sep 2Same dayConnaughton BernadetteDirectorSSale−4.00K$73.69−$294.7K−7.9%47.0K after3 lots10b5-1